NRx subsidiary HOPE signs non-binding LOI to acquire Florida Interventional Psychiatry Clinics

NRX Pharmaceuticals, Inc.

HOPE Therapeutics, NRx subsidiary, signs LOI for first Interventional Psychiatry Clinics in Florida.
Clinics are revenue generating and EBITDA positive; acquisition expected to be immediately accretive.
Acquisition subject to definitive documentation and receipt of adequate financing.
Clinics will form foundation for HOPE's growth in Florida; founders to help optimize additional acquisitions.
NRx and HOPE aim to establish a model for CNS care clinics nationwide.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.